Deutsche Bank’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ELTX
KCM
Deutsche Bank's ELTX Position: Q3 2026 in Review
Deutsche Bank reduced its Elicio Therapeutics (ELTX) stake by 13% in Q3 2026, selling an estimated $4.54K and leaving 11,016 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #3552.
Deutsche Bank first reported a position in ELTX in Q1 2021 and has held it in 7 quarters since. The position peaked at $138K in Q3 2021. 79 funds tracked by Wall St. Rank hold ELTX as of Q3 2026.
- Deutsche Bank held 11,016 shares of Elicio Therapeutics worth $20K as of Q3 2026.
- Deutsche Bank sold 1,636 Elicio Therapeutics shares in Q3 2026, an estimated $4.54K.
- Elicio Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3552 holding.
- Deutsche Bank first reported a position in Elicio Therapeutics in Q1 2021 and has held it in 7 quarters since.
- Deutsche Bank's Elicio Therapeutics position peaked at $138K in Q3 2021.
- 79 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.